依达拉奉治疗35例急性脑出血的临床疗效分析  

CLINICAL EFFICACY OF EDARAVONE ON THE TREATMENT OF ACUTE HEMORRHAGE IN 35 PATIENTS

作　　者：孙艳梅[1] 杨学传[2] 

机构地区：[1]华北煤炭医学院临床医学系,唐山063000 [2]华北煤炭医学院办公室

出　　处：《现代预防医学》2012年第1期252-253,共2页Modern Preventive Medicine

摘　　要：[目的]观察依达拉奉治疗急性脑出血的临床疗效。[方法]将70例急性脑出血者随机分为治疗组和对照组。治疗组在常规治疗基础上给予依达拉奉应用共14 d。对照组给予常规治疗,疗程同依达拉奉组,分别于治疗前及治疗后14 d进行神经功能缺损程度及临床疗效评定。[结果]治疗14 d后,治疗组神经功能缺损程度评分明显低于对照组(t=2.75,P﹤0.05);治疗组的有效率显著高于对照组(χ2=4.16,P﹤0.05)。[结论依达拉奉治疗急性脑出血安全有效。[Objective]To observe the clinical therapeutic effects of edaravone on acute cerebral hemorrhage.[Methods]70 patients were randomly divided into two groups,treatment group and control group.35 patients in the treatment group were given edaravone in addition to the routine therapy for 14 days and the other 35 patients were treated routinely for 14 days.Before and after 14 days,patients in 2 groups were recorded about neurological function deficit scores and efficacy assessment.[Results]14 days after the termination of the treatment,the neurological functional deficit scores in treatment group were much lower than that in control group（t = 2.75,P﹤0.05）;effective rates in treatment group were significantly higher than those in control group（χ2 = 4.16,P﹤0.05）.[Conclusion]Edaravone can cure acute cerebral hemorrhage safely and effectively.

关 键 词：依达拉奉 脑出血 疗效 

分 类 号：R743.34[医药卫生—神经病学与精神病学]